drugset / Trial / NCT05742438

Effects of Dexmedetomidine/Lidocaine/Intrathecal Morphine on Cancer Metastasis Biomarker After Colorectal Surgery

NCT05742438 ↗

RandomizedParallel-groupTriple-blindOther

Summary

This is a prospective randomized controlled trial. Investigators aimed to compare the effect of three different anesthetic adjuvants (continuous infusion of lidocaine or dexmedetomidine, intrathecal morphine injection) on the biomarker for cancer recurrence and metastasis. Patients undergoing elective colorectal cancer surgery will be randomly allocated to three parallel arms and the biomarkers for cancer recurrence and metastasis, inflammation, and immune response will be compared. And we will compare the clinical outcomes in the three method.

Timeline

Start
2023-04-12
Primary completion
2023-07-05
Completion
2023-08-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dexmedetomidine Other / unclassified 0.3 ug/kg Intravenous
Comparator Lidocaine Other / unclassified 1.5 mg/kg Intravenous
Comparator Morphine Other / unclassified 200 ug Intrathecal
Comparator Morphine Other / unclassified 300 ug Intrathecal